Fraser Brown is an associate in the Patent Counseling and Prosecution practice group. He joined Cooley in 2012 and resides in the Washington, DC office.
Dr. Brown's practice focuses on biotechnology issues, with particular emphasis on drafting and prosecuting patent applications, and preparing invalidity, freedom to operate and patentability opinions. Dr. Brown has also negotiated agreements to further clients' collaborative research and development strategies. Dr. Brown has counseled clients on a range of technical areas including vaccines, fluorescent proteins, drug design and screening, and cancer therapies.
Prior to joining Cooley, Dr. Brown was at Banner & Witcoff, Ltd. in their Washington, DC office.
Dr. Brown holds a PhD in biochemistry from the University of Birmingham, England where he researched cell signaling pathways, particularly phospholipases and lipid kinases, associated with immune cells. Dr. Brown also spent seven years performing molecular cell biology research in the National Heart, Lung and Blood Institute at the National Institutes of Health in Bethesda, MD, where he investigated the regulation and role of GTPases in controlling cell membrane structure using antibody- and live cell imaging-based approaches.
Dr. Brown's research is published in the Journal of Cell Biology and the Journal of Biological Chemistry, amongst others. Dr. Brown has also published several articles relating to intellectual property issues facing the biotechnology industry.
Dr. Brown obtained his JD in 2008 from the Georgetown University Law Center. He is admitted to practice in the jurisdictions of California and the District of Columbia and has limited recognition to practice before the United States Patent and Trademark Office.
- Georgetown University Law Center
- University of Birmingham
- Glasgow, Univ of
- District of Columbia
- Limited Recognition to practice before the United States Patent & Trademark Office (USPTO)